Connexin36 (Cx36), a trans-
membrane protein that forms gap junctions between
insulin-secreting beta-cells in the Langerhans islets, contributes to the proper control of insulin secretion and beta-cell survival.
Hypercholesterolemia and pro-atherogenic
low density lipoproteins (
LDL) contribute to beta-cell dysfunction and apoptosis in the context of
Type 2 diabetes. We investigated the impact of
LDL-cholesterol on Cx36 levels in beta-cells. As compared to WT mice, the Cx36 content was reduced in islets from hypercholesterolemic
ApoE-/- mice. Prolonged exposure to human native (nLDL) or
oxidized LDL (
oxLDL) particles decreased the expression of Cx36 in insulin secreting cell-lines and isolated rodent islets. Cx36 down-regulation was associated with overexpression of the inducible cAMP early repressor (ICER-1) and the selective disruption of ICER-1 prevented the effects of
oxLDL on Cx36 expression.
Oil red O staining and Plin1 expression levels suggested that
oxLDL were less stored as neutral lipid droplets than nLDL in INS-1E cells. The
lipid beta-oxidation inhibitor
etomoxir enhanced
oxLDL-induced apoptosis whereas the
ceramide synthesis inhibitor
myriocin partially protected INS-1E cells, suggesting that
oxLDL toxicity was due to impaired metabolism of the
lipids. ICER-1 and Cx36 expressions were closely correlated with
oxLDL toxicity. Cx36 knock-down in INS-1E cells or knock-out in primary islets sensitized beta-cells to
oxLDL-induced apoptosis. In contrast, overexpression of Cx36 partially protected INS-1E cells against apoptosis. These data demonstrate that the reduction of Cx36 content in beta-cells by
oxLDL particles is mediated by ICER-1 and contributes to
oxLDL-induced beta-cell apoptosis.